From the ∗Department of Child and Adolescent Psychiatry, Dokuz Eylul University, School of Medicine, Izmir
†Mehmet Akif Inan Training and Research Hospital, Sanliurfa
‡Department of Anesthesiology and Reanimation, Dokuz Eylul University, School of Medicine
§Department of Medical Physics, Dokuz Eylul University, Health Sciences Institute, Izmir, Turkey
∥Department of Psychiatry, University of Utah, School of Medicine
¶The Rocky Mountain Veterans Integrated Service Network 19, Mental Illness Research, Education, and Clinical Center of Excellence, Salt Lake City, UT
#Department of Psychiatry, Dokuz Eylul University, School of Medicine, Izmir, Turkey.
Received for publication September 27, 2020; accepted January 28, 2021.
Reprints: Cagatay Ermis, MD, Department of Child and Adolescent Psychiatry, Dokuz Eylul University, School of Medicine, Mithatpasa St., Postcode: 35330, Balcova, Izmir, Turkey (e-mail: [email protected]).
Supported by an independent investigator grant from the Pfizer, Inc, New York, NY (to A.Y.), Harvard Medical School Stanley Foundation Bipolar Disorders Research Center, Belmont, MA (to A.Y.), and International Sleep Research Foundation, Houston, TX (to A.Y.). Funding sources had no role in study design, in the collection, analysis, and interpretation of data, in the writing of the report, or in the decision to submit the paper for publication. Trial registration number: ISRCTN-28600786, http://www.controlled-trials.com/ISRCTN28600786/. The other authors have no conflicts of interest or financial disclosures to report.
